Can Wellbutrin (bupropion) cause hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Wellbutrin Cause Increased Blood Pressure?

Yes, bupropion (Wellbutrin) can cause elevated blood pressure and hypertension, and blood pressure monitoring is required during treatment. 1

FDA-Mandated Warnings and Monitoring

The FDA drug label explicitly states that treatment with bupropion can result in elevated blood pressure and hypertension. 1 Blood pressure must be assessed before initiating treatment and monitored periodically during therapy. 1

Key Clinical Data from FDA Label

  • In seasonal affective disorder trials, 2% of bupropion-treated patients (11/537) developed hypertension versus 0% on placebo (0/511), with 2 patients discontinuing due to hypertension. 1
  • Mean systolic blood pressure increased by 1.3 mmHg in the bupropion group versus 0.1 mmHg in placebo (statistically significant, p=0.013). 1
  • Mean diastolic blood pressure increased by 0.8 mmHg in the bupropion group versus 0.1 mmHg in placebo. 1
  • When combined with nicotine replacement therapy, 6.1% of patients developed treatment-emergent hypertension compared to 2.5% with bupropion alone. 1

Guideline Recommendations for Monitoring

For patients taking naltrexone-bupropion ER for weight management, blood pressure and heart rate should be monitored periodically, especially in the first 12 weeks of treatment. 2 The American Gastroenterological Association recommends avoiding naltrexone-bupropion ER in patients with uncontrolled hypertension. 3, 2

Risk Factors for Hypertension with Bupropion

The risk of hypertension is substantially increased when bupropion is used concomitantly with: 1

  • MAO inhibitors
  • Other drugs that increase dopaminergic or noradrenergic activity
  • Nicotine replacement therapy (particularly nicotine patches)

Clinical Trial Evidence

Patients with Mild Hypertension

A randomized, double-blind, placebo-controlled trial in 300 community volunteers with untreated stage 1 hypertension found that bupropion SR 300 mg/day resulted in less reduction in systolic blood pressure compared to placebo (-4.20 vs -6.53 mmHg; p=0.020). 4 Heart rate increases were small but statistically significant at 400 mg/day versus placebo (2.28 vs -0.64 beats/min; p=0.004). 4

Patients with Cardiovascular Disease

In a study of 36 depressed inpatients with preexisting heart disease, bupropion caused a rise in supine blood pressure, and treatment was discontinued in 14% of patients due to adverse effects, including exacerbation of baseline hypertension in 2 patients. 5 However, bupropion had a low rate of orthostatic hypotension compared to tricyclic antidepressants. 5

Comparison to Other Antidepressants

According to the 2020 International Society of Hypertension guidelines, different antidepressant classes have varying effects on blood pressure: 3

  • SNRIs (serotonin-norepinephrine reuptake inhibitors): 2/1 mmHg increase
  • Tricyclic antidepressants: Increased odds ratio of 3.19 for hypertension
  • SSRIs (selective serotonin reuptake inhibitors): No increases in blood pressure

A comprehensive review confirms that bupropion, as a dopamine-norepinephrine reuptake inhibitor, can lead to blood pressure increases, usually at high doses. 6

Clinical Pitfalls and Practical Considerations

Common pitfall: Failing to monitor blood pressure in the first 12 weeks of treatment when hypertensive effects are most likely to manifest. 2

Important caveat: While bupropion can cause hypertension, it paradoxically has a lower risk of orthostatic hypotension compared to tricyclic antidepressants, making it potentially safer in patients prone to postural blood pressure drops. 7, 5, 8

Dose-dependent effect: The hypertensive effect appears dose-related, with higher doses (≥300 mg/day) showing more pronounced effects. 1, 4

References

Guideline

Bupropion-Associated Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressant Drugs Effects on Blood Pressure.

Frontiers in cardiovascular medicine, 2021

Research

The cardiovascular profile of bupropion.

The Journal of clinical psychiatry, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.